PMV Pharmaceuticals
Latest round
- Series D
Last raised
- Jul 2020
Total raised
- $236M
Investors
- 11
About PMV Pharmaceuticals
PMV Pharmaceuticals, Inc.Founded in 2013 and headquartered in the United States, PMV Pharmaceuticals, Inc. specializes in cancer therapies targeting the mutated p53 protein.7 mn in an IPO on September 24, 2020, indicating a significant advancement in their operational strategy.PMV Pharma’s core focus revolves around the development of innovative therapies that target the p53 protein, a critical tumor suppressor that is often mutated in various cancers. The company employs a unique approach to restore the normal function of mutated p53 proteins by structurally correcting their geometry, thus reestablishing their tumor-suppressing capabilities. These therapies are aimed at treating various cancer types where p53 mutations play a significant role, including breast, lung, and colorectal cancers. PMV Pharma's product offerings are currently in various stages of clinical trials, indicating a commitment to advancing the science of p53 in oncology.PMV Pharma generates revenue primarily through partnerships and collaborations with other pharmaceutical companies, facilitating the advancement of its proprietary therapies from clinical development into potential commercialization. The revenue structure involves milestone payments, royalties on future sales, and co-development agreements based on the successful progression of their clinical trials. As the company’s therapies advance through developmental phases, it may establish further agreements with healthcare organizations and research institutions to bolster its market presence. Specific financial details regarding pricing plans or transactional structures are not disclosed, but the emphasis remains on fostering strategic partnerships within the oncology sector to enhance therapeutic reach and efficacy.
Who invested in PMV Pharmaceuticals
11 investors across 4 rounds
See all investors in PMV Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PMV Pharmaceuticals
Who invested in PMV Pharmaceuticals?
PMV Pharmaceuticals has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PMV Pharmaceuticals raised?
PMV Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did PMV Pharmaceuticals last raise money?
PMV Pharmaceuticals's most recent round on record is a Series D, in Jul 2020.
What does PMV Pharmaceuticals do?
PMV Pharmaceuticals is a biotechnology company.
Where is PMV Pharmaceuticals headquartered?
PMV Pharmaceuticals is headquartered in Princeton, US.
Which VCs invest in companies like PMV Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PMV Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like PMV Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.